Upper GI Bleeding Clinical Trial
Official title:
Evaluation of Clinical Risk Scores in Prediction of Outcome of Acute Upper Gastrointestinal Bleeding in Non Cirrhotic Patients
To compare the ability of 4 bleeding risk scoring systems (Glasgow -Blatchford score, MAP, H3B2 and ABC scores ) in prediction of: Need of intervention, Re bleeding, Thirty-day mortality, length of hospital stay
Acute upper gastrointestinal bleeding (UGIB) is a common medical emergency which has a variceal and non-variceal etiology. The non variceal etiology has higher incidence in many countries. In Egypt, non-variceal causes ranged from 26.1% to 61.6% among UGIB cases presented to the emergency departments of different University Hospitals. Guidelines recommend risk stratification early in the management of patients with acute UGIB to help triage patients into the appropriate level of care. Many scoring systems for UGIB were developed and validated from 1990s onwards. Their primary aim was to segregate the patients into low-risk and high-risk groups. High risk patients with UGIB includes those who reach some or all of the endpoints: requirement of blood transfusion, endo-therapeutic, surgical or radiological intervention to achieve hemostasis, re bleeding and mortality. Unfortunately, no single risk score has been shown to be accurate at measuring all relevant outcomes. The most widely used score is Glasgow Blatchford "GBS" which is a pre endoscopic score. It is useful in prediction of therapeutic intervention for bleeding. More recently, other scores have been developed as ABC score which showed good performance for predicting mortality. MAP score highly predicted therapeutic intervention and mortality. H3B2 score predicted the need of urgent hemostasis. Limited data are available on the validity of the new scoring systems in predicting the outcome of Egyptian non-cirrhotic patients with acute UGIB. Therefore, The investigators will conduct our study to shed some light on this topic. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01448382 -
Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study
|
Phase 1 | |
Recruiting |
NCT06167837 -
Metoclopramide for Gastric Visualization in Active Upper GI Bleeding
|
Phase 4 | |
Recruiting |
NCT05746377 -
Metoclopramide in Upper Gastrointestinal Bleed
|
Phase 4 | |
Recruiting |
NCT05582174 -
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
|
Phase 4 | |
Recruiting |
NCT05415124 -
Presence or Absence of Blood in the GI Lumen
|
N/A | |
Recruiting |
NCT05474937 -
Inhalation of Sevoflurane Versus Intravenous Midazolam,Ketamine,Propofol For Pediatrics Undergoing Upper GI Endoscopy
|
N/A | |
Recruiting |
NCT05457062 -
Analysis the Vocs in Upper GI Bleeding Patients
|
||
Recruiting |
NCT05876741 -
Validation of Prognostic Accuracy of ABC ( Age, Blood Urea Nitrogen , Co-morbidities ) and Horibe Pre-endoscopy Scoring Systems in Patients With Upper Gastrointestinal Bleeding in Sohag University Hospital .
|
||
Recruiting |
NCT05763745 -
Bedside Ultrasonic Assessment for Gastric Content in Patients With Upper GI Bleeding Undergoing Endoscopy: a Pilot Study
|
N/A | |
Completed |
NCT03176407 -
Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING]
|
N/A |